Committee's action will undermine further research and development

BMJ 1995; 311 doi: https://doi.org/10.1136/bmj.311.7020.1639c (Published 16 December 1995) Cite this as: BMJ 1995;311:1639
  1. Victor Wynn,
  2. Ian F Godsland,
  3. David Crook,
  4. John C Stevenson
  1. Chairman Lecturer Lecturer Director Wynn Division of Metabolic Medicine, National Heart and Lung Institute, Imperial College of Science, Technology and Medicine, London NW8 9SQ

    EDITOR,--We deplore the failure of the Committee on Safety of Medicines and its chairman, Professor Michael Rawlins, to understand the issues raised by their hasty and ill considered advice to doctors not to prescribe oral contraceptives containing the progestogens desogestrel and gestodene.1 Rawlins claims that the committee has to take on the responsibilities of peer reviewers with regard to unpublished information.2 In this it presumes to act as both judge and jury, a single role that …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription